It is a chemicals private limited company based in Bhubaneswar, Orissa, India, established in 2013.
2013 | Bhubaneswar, Orissa, India | ActiveSynthergen Therapeutics Private Limited, a active private limited company, was established on 15 March 2013 in Bhubaneswar, Orissa, India. Engaging in medicinal chemical & botanical products within the chemicals sector, it holds CIN: U74900OR2013PTC016658. Registered under ROC Roc Cuttack. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹1.00 M.
It upholds a compliant status. Its leadership includes Sushree Bhatta (Director), Susil Kumar Kasta (Director). Past directors included Sujit Kumar Kasta, Tushar Ranjan Mallick. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Plot No. 285 Damana, Chandrasekharpur, Bhubaneswar, Orissa, 751016.
U74900OR2013PTC016658
016658
15 March 2013
₹1.00 M
₹1.00 M
Roc Cuttack
Unlisted
Active
Explore comprehensive insights into Synthergen Therapeutics Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sushree Bhatta | Director | 15 Mar 2013 | Current |
| Susil Kumar Kasta | Director | 20 May 2014 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 10 Oct 2018 | Past |
| Pramod Abcsdd | Managing Director | 03 Jun 2014 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Synthergen Therapeutics Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 67837.38% increase. The company also saw a substantial improvement in profitability, with a 129.85% increase in profit. The company's net worth moved up by a moderate rise of 5.17%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2017, Synthergen Therapeutics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Synthergen Therapeutics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Synthergen Therapeutics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Synthergen Therapeutics's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Synthergen Therapeutics Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Progress on Synthergen Therapeutics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Cuttack. was documented.
Susil Kumar Kasta was appointed as a Director was appointed as a Director on 20 May 2014 & has been associated with this company since 11 years 6 months . was recorded as a recent event.
Progress on Sushree Bhatta was appointed as a Director was appointed as a Director on 15 Mar 2013 & has been associated with this company since 12 years 8 months . was documented.
Progress on Synthergen Therapeutics Private Limited was registered on 15 Mar 2013 with Roc Cuttack & aged 12 years 8 months as per MCA records. was documented.
The CIN of Synthergen Therapeutics Private Limited is U74900OR2013PTC016658.
Synthergen Therapeutics Private Limited is headquartered at Plot No. 285 Damana, Chandrasekharpur, Bhubaneswar, Orissa, 751016.
Synthergen Therapeutics Private Limited was incorporated on 15 March 2013.
The current directors of Synthergen Therapeutics Private Limited are
The primary industry of Synthergen Therapeutics Private Limited is Chemicals.
Synthergen Therapeutics Private Limited is unlisted.
The authorized capital of Synthergen Therapeutics Private Limited is ₹1.00 M, and the paid-up capital is ₹1.00 M.
The compliance status of Synthergen Therapeutics Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX